Discovery of Antimalarial Drugs from Streptomycetes Metabolites Using a Metabolomic Approach. (16th October 2017)

• Record Type: Journal Article
• Authors: Ahmad, Siti Junaidah; Abdul Rahim, Mohd Badrin Hanizam; Baharum, Syarul Nataqain; Baba, Mohd Shukri; Zin, Noraziah Mohamad
• Other Names: Gonzalez Jean-Paul J. Academic Editor.
• Is Part Of: Journal of tropical medicine. Volume 2017(2017)
• Publication Date: 2017-10-16
• Subjects: Tropical medicine -- Periodicals; 616.9883
• DOI: 10.1155/2017/2189814
• Languages: English
• ISSNs: 1687-9686

Abstract

Abstract : Natural products continue to play an important role as a source of biologically active substances for the development of new drug. Streptomyces, Gram-positive bacteria which are widely distributed in nature, are one of the most popular sources of natural antibiotics. Recently, by using a bioassay-guided fractionation, an antimalarial compound, Gancidin-W, has been discovered from these bacteria. However, this classical method in identifying potentially novel bioactive compounds from the natural products requires considerable effort and is a time-consuming process. Metabolomics is an emerging "omics" technology in systems biology study which integrated in process of discovering drug from natural products. Metabolomics approach in finding novel therapeutics agent for malaria offers dereplication step in screening phase to shorten the process. The highly sensitive instruments, such as Liquid Chromatography-Mass Spectrophotometry (LC-MS), Gas Chromatography-Mass Spectrophotometry (GC-MS), and Nuclear Magnetic Resonance ( 1 H-NMR) spectroscopy, provide a wide range of information in the identification of potentially bioactive compounds. The current paper reviews concepts of metabolomics and its application in drug discovery of malaria treatment as well as assessing the antimalarial activity from natural products. Metabolomics approach in malaria drug discovery is still new and needs to be initiated, especially for drug research in Malaysia.